Patriot Financial Group Insurance Agency’s Tvardi Therapeutics TVRD Stock Holding History
Bought
Maintained
Sold
Other funds holding TVRD
BCLSI
FCM
DGI
KCM
C
Patriot Financial Group Insurance Agency's TVRD Position: Q1 2023 in Review
Patriot Financial Group Insurance Agency sold out of Tvardi Therapeutics (TVRD) in Q1 2023, closing a stake of 322 shares — an estimated $125K sold.
Patriot Financial Group Insurance Agency first reported a position in TVRD in Q4 2016 and held it in 20 quarters. The position peaked at $501K in Q1 2022. 163 funds tracked by Wall St. Rank hold TVRD as of Q1 2023.
- Patriot Financial Group Insurance Agency reported no remaining Tvardi Therapeutics position as of Q1 2023 after selling out during the quarter.
- Patriot Financial Group Insurance Agency sold 322 Tvardi Therapeutics shares in Q1 2023, an estimated $125K.
- Patriot Financial Group Insurance Agency first reported a position in Tvardi Therapeutics in Q4 2016 and held it in 20 quarters.
- Patriot Financial Group Insurance Agency's Tvardi Therapeutics position peaked at $501K in Q1 2022.
- 163 funds tracked by Wall St. Rank held Tvardi Therapeutics as of Q1 2023.
Based on Patriot Financial Group Insurance Agency's 13F filing for Q1 2023, filed 20 Apr 2023.